公开(公告)号：GR852254B

公开(公告)日：1986-01-17

申请号：GR850102254

申请日：1985-09-17

Applicant: HOECHST AG

Inventor： SEEGER KARL DR ,  FULBERTH WERNER DR ,  LEINEWEBER MICHAEL DR ,  OBERMEIER RAINER DR ,  ROLLY HEINRICH DR

IPC: C07K14/52 ,  A61K38/21 ,  C07K14/555 ,  C07K14/56

公开(公告)号：DE3260227D1

公开(公告)日：1984-07-19

申请号：DE3260227

申请日：1982-02-12

Applicant: HOECHST AG

Inventor： FULBERTH WERNER DR ,  SICKMULLER ALFRED DR ,  STAMMBERGER WILLI DR

IPC: A23L1/00 ,  A23L2/60 ,  A23L27/30 ,  A23P1/02 ,  A61J3/10 ,  A61K9/46 ,  A23L1/236

公开(公告)号：DE3165050D1

公开(公告)日：1984-08-30

申请号：DE3165050

申请日：1981-07-01

Applicant: HOECHST AG

Inventor： MUSCHAWECK ROMAN DR ,  FULBERTH WERNER DR ,  SICKMULLER ALFRED DR

IPC: C07D295/14 ,  A61K31/13 ,  A61K31/135 ,  A61K31/275 ,  A61K31/34 ,  A61K31/341 ,  A61K31/40 ,  A61K31/402 ,  A61K31/635 ,  A61P9/12 ,  C07D295/08 ,  C07D295/155 ,  C07D307/52

Abstract: Salts formed between penbutolol and furosemide or piretanide, pharmaceutical compositions containing such salts, and methods for treating diseases of the coronary and circulatory systems with such salts.

公开(公告)号：GR852955B

公开(公告)日：1986-04-01

申请号：GR850102955

申请日：1985-12-09

Applicant: HOECHST AG

Inventor： FULBERTH WERNER DR ,  FREVER HANS-GEORG

IPC: A61K35/39 ,  A61K9/22 ,  A61K9/28 ,  A61K9/30 ,  A61K9/32 ,  A61K38/46 ,  A61K38/54 ,  C12N9/94

Abstract: A process for the preparation of pancreatic enzyme products in compressed form is described. A water-based insulating layer and a final lacquer based on organic solvents are applied to the core which contains the active compounds.

公开(公告)号：DE2860033D1

公开(公告)日：1980-11-13

申请号：DE2860033

申请日：1978-06-01

Applicant: HOECHST AG

Inventor： SCHMITT KARL DR ,  HOFFMANN IRMGARD DR ,  FULBERTH WERNER DR ,  STAMMBERGER WILLI DR

IPC: A61K31/47 ,  A61K31/55 ,  A61P25/24 ,  A61P25/26

Abstract: What is disclosed are medicinal compositions, useful as anti-depressive agents, containing a compound of the formula; (I) in which R1, R3 and R4, which may be identical or different, and represent hydrogen atoms or lower alkyl or aralkyl groups, and R2 and R2', which may be identical or different, represent hydrogen or halogen atoms, hydroxy or trifluoromethyl groups or lower alkyl, alkoxy or aralkoxy groups, it also being possible that two adjacent radicals form an alkylene-dioxy radical, and R5 represents a hydrogen or halogen atom, a hydroxy, trifluoromethyl or nitro group or a lower alkyl, alkoxy or aralkoxy radical, and their salts with acids (active substance A) together with 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4 (3H,5H)-dione (active substance B), and their use as antidepressive agent.